Results 111 to 120 of about 13,355 (171)

Early MMR Vaccine Adoption During the 2025 Texas Measles Outbreak.

JAMA Netw Open
Goodwin Cartwright BM, Masters NB, Gilbert KM, Rodriguez PJ, Do D, Stucky N.   +5 more
europepmc   +1 more source

A Comparative Study of the Efficacy of Intralesional Measles Mumps Rubella (MMR) Vaccine and Auto Implantation for the Treatment of Periungual and Palmoplantar Warts: A Randomized Controlled Trial. [PDF]

Indian Dermatol Online J
Abusaria R, Yadav C, Jain V, Kachhawa D, Rao P, Lamoria A.   +5 more
europepmc   +1 more source

MMR Vaccine Adverse Drug Reactions Reports in the CDC WONDER System, 1989-2019. [PDF]

Open Forum Infect Dis, 2020
Rodriguez-Nava G, Trelles-Garcia DP, Yanez-Bello MA, Imani-Ramos T, Trelles-Garcia VP, Bustamante-Soliz DS, Patiño-Salamea E.   +6 more
europepmc   +1 more source

Early B cell transcriptomic markers of measles-specific humoral immunity following a 3^rd dose of MMR vaccine. [PDF]

Front Immunol
Haralambieva IH, Chen J, Quach HQ, Ratishvili T, Warner ND, Ovsyannikova IG, Poland GA, Kennedy RB.   +7 more
europepmc   +1 more source

MMR vaccine debate [PDF]

BMJ, 2002
openaire   +2 more sources

Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study. [PDF]

Sci Rep
Zaky MS, Atallah RB, Mohyeldeen AMS, Elsaie ML.   +3 more
europepmc   +1 more source

Comparison of Effectiveness and Safety of Immunotherapy of Warts with Intralesional Versus Subcutaneous MMR Vaccine: An Open Label Randomized, Parallel Group, Clinical Trial.

Indian J Dermatol, 2022
Saha A, Bahalia I, Agarwal S, Banerjee A, Bandyopadhyay D.   +4 more
europepmc   +1 more source

The facts on MMR vaccine

Weekly releases (1997–2007), 2001
openaire   +1 more source

MMR (measles-mumps-rubella) vaccine [PDF]

Paediatrics & Child Health, 2001
openaire   +2 more sources